ALLR
Allarity Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.87
−2.46%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.88
From 52W high−50.68%
Volume85265.00
Market cap$13.89M
P/E (TTM)—
P/S (TTM)40.3x
Div yield—
Key dataOct 19, 2026
Open
$0.88
From 52W high
−50.68%
Volume
85265.00
Market cap
$13.89M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.7x
P/E (TTM)
—
RSI (14)
32.8
MomentumView details →
1D Return
−2.46%
YTD Return
−20.37%
SummaryUpdated Jun 1, 2026
Allarity Therapeutics, Inc. (NASDAQ:ALLR) is a clinical-stage biopharmaceutical company founded in 2004 and headquartered in Cambridge, Massachusetts. The company went public in December 2021 and focuses on developing oncology therapeutics using proprietary drug response predictor technology to create companion diagnostics. Allarity operates in the highly specialized field of precision oncology, where treatments are tailored to individual patients based on their likelihood to respond to specific cancer drugs.
Similar companies
Latest newsMore news →